| Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts MR Pitari, M Rossi, N Amodio, C Botta, E Morelli, C Federico, A Gullà, ... Oncotarget 6 (29), 27343, 2015 | 93 | 2015 |
| Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET … MT Di Martino, M Arbitrio, E Leone, PH Guzzi, M Saveria Rotundo, ... Cancer biology & therapy 12 (9), 780-787, 2011 | 93 | 2011 |
| In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor P Neri, P Tagliaferri, MT Di Martino, T Calimeri, N Amodio, A Bulotta, ... British journal of haematology 143 (4), 520-531, 2008 | 77 | 2008 |
| DMET-analyzer: automatic analysis of Affymetrix DMET data PH Guzzi, G Agapito, MT Di Martino, M Arbitrio, P Tassone, P Tagliaferri, ... BMC bioinformatics 13 (1), 1-10, 2012 | 73 | 2012 |
| Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time? I Cucinotto, L Fiorillo, S Gualtieri, M Arbitrio, D Ciliberto, N Staropoli, ... Journal of Drug Delivery 2013, 2013 | 69 | 2013 |
| Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis M Arbitrio, MT Di Martino, V Barbieri, G Agapito, PH Guzzi, C Botta, ... Cancer chemotherapy and pharmacology 77 (1), 205-209, 2016 | 66 | 2016 |
| A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients … MT Di Martino, M Arbitrio, PH Guzzi, E Leone, F Baudi, E Piro, T Prantera, ... British journal of haematology 154 (4), 529, 2011 | 65 | 2011 |
| DMET™(Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine M Arbitrio, MT Di Martino, F Scionti, G Agapito, PH Guzzi, M Cannataro, ... Oncotarget 7 (33), 54028, 2016 | 59 | 2016 |
| Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma MA Stamato, G Juli, E Romeo, D Ronchetti, M Arbitrio, D Caracciolo, ... Oncotarget 8 (63), 106527, 2017 | 50 | 2017 |
| Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates MEG Cantafio, BS Nielsen, C Mignogna, M Arbitrio, C Botta, NM Frandsen, ... Molecular Therapy-Nucleic Acids 5, e326, 2016 | 43 | 2016 |
| Mouse models of multiple myeloma: technologic platforms and perspectives M Rossi, C Botta, M Arbitrio, RD Grembiale, P Tagliaferri, P Tassone Oncotarget 9 (28), 20119, 2018 | 42 | 2018 |
| Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms G Nisticó, MC Caroleo, M Arbitrio, L Pulvirenti Neuroimmunomodulation 1 (3), 174-180, 1994 | 40 | 1994 |
| Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and blood … D Frasca, F Guidi, M Arbitrio, C Pioli, F Poccia, R Cicconi, G Doria Bone marrow transplantation 25 (4), 427-433, 2000 | 39 | 2000 |
| miR-22 suppresses DNA ligase III addiction in multiple myeloma D Caracciolo, MT Di Martino, N Amodio, E Morelli, M Montesano, C Botta, ... Leukemia 33 (2), 487-498, 2019 | 37 | 2019 |
| From single level analysis to multi-omics integrative approaches: a powerful strategy towards the precision oncology ME Gallo Cantafio, K Grillone, D Caracciolo, F Scionti, M Arbitrio, ... High-throughput 7 (4), 33, 2018 | 30 | 2018 |
| BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality? P Tagliaferri, M Ventura, F Baudi, I Cucinotto, M Arbitrio, MT Di Martino, ... Journal of ovarian research 2 (1), 1-9, 2009 | 30 | 2009 |
| IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation D Frasca, C Pioll, F Guidi, S Pucci, M Arbitrio, G Later, G Doria International immunology 8 (11), 1651-1657, 1996 | 27 | 1996 |
| A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity MC Caroleo, M Arbitrio, D Melchiorri, G Nisticò Neuroimmunomodulation 1 (2), 141-147, 1994 | 25 | 1994 |
| Genetic variants associated with gastrointestinal symptoms in Fabry disease MT Di Martino, F Scionti, S Sestito, A Nicoletti, M Arbitrio, PH Guzzi, ... Oncotarget 7 (52), 85895, 2016 | 24 | 2016 |
| Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma D Caracciolo, F Scionti, G Juli, E Altomare, G Golino, K Todoerti, ... Haematologica 106 (1), 185, 2021 | 22 | 2021 |
Pierosandro Tagliaferriprofessore di oncologia medica Università magna graecia di CatanzaroVerified email at unicz.it
